Request Deal Involvement
Avista-backed Acino completed the acquisition of Takeda Pharmaceutical's drug portfolio for $200m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Rothschild & Co
accounting advisors
PricewaterhouseCoopers
commercial advisors
McKinsey & Company
legal advisors
Latham & Watkins
financial advisors
Deloitte
financial advisors
Bank of America
legal advisors
White & Case
pr advisors
Sard Verbinnen & Co
pr advisors
Kekst CNC
or
Principals
bidder
ACINO INTERNATIONAL AG
vendor
TAKEDA PHARMACEUTICAL COMPANY LIMITED
target
TAKEDA PHARMACEUTICAL COMPANY LIMITED (DRUG PORTFOLIO)
bidder
AVISTA HEALTHCARE PARTNERS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite